Polymorphisms in the Promoter Region of the CRBN Gene as a Predictive Factor for the First-Line CTD Therapy in Multiple Myeloma Patients
Oncotarget - United States
doi 10.18632/oncotarget.25307
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 21, 2018
Authors
Publisher
Impact Journals, LLC